Aditxt, Inc. Supplemental Deferred Purchase Price
Aditxt, Inc. (ADTX) had Supplemental Deferred Purchase Price of $75.14 thousand as of 2024-05-20, per its 10-Q filed 2025-05-15.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:SupplementalDeferredPurchasePrice · last filed 2025-05-15
- 2024-05-20: Supplemental Deferred Purchase Price $75.14K.
- 2022-09-12: Supplemental Deferred Purchase Price 0 month $555.55K.
- 2022-08-11: Supplemental Deferred Purchase Price $555.56K.
- 2022-08-04: Supplemental Deferred Purchase Price $1.28M.
| Period end | Supplemental Deferred Purchase Price | Supplemental Deferred Purchase Price 0 month |
|---|---|---|
| 2024-05-20 | $75.14K 10-Q · filed 2025-05-15 | |
| 2022-09-12 | $555.55K 10-Q · filed 2022-11-14 | |
| 2022-08-11 | $555.56K 10-Q · filed 2022-11-14 | |
| 2022-08-04 | $1.28M 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |